You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 66 No. 5, May 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Cognitive Disorders
 •Neurology, Other
 •Otolaryngology/ Head & Neck Surgery
 •Diagnosis
 •Thyroid/ Parathyroid Diseases
 •Genetic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hashimoto Encephalopathy and Down Syndrome

Amy Brodtmann, MD, PhD

Arch Neurol. 2009;66(5):663-666.

Background  Hashimoto encephalopathy is a potentially fatal condition associated with a presentation of myoclonus, altered conscious state, strokelike episodes, rapid cognitive decline, and neuropsychiatric symptoms. Both congenital hypothyroidism and acquired hypothyroidism are common in patients with Down syndrome.

Objective  To describe the presentation of Hashimoto encephalopathy in patients with Down syndrome.

Design  Clinical case reports.

Setting  General neurology unit.

Patients  Two Down syndrome patients diagnosed as having Hashimoto encephalopathy are described.

Intervention  High-dose oral corticosteroids.

Main Outcome Measures  Neurologic examination, electroencephalography, and blood analysis results.

Results  Both patients responded to treatment, with a slow return to their premorbid level of function.

Conclusion  Hashimoto encephalopathy should be considered in Down syndrome patients with rapidly progressive cognitive decline.


Author Affiliations: Eastern Cognitive Disorders Clinic, Box Hill Hospital, Melbourne, Australia. Dr Brodtmann is also affiliated with the National Stroke Research Institute, Heidelberg, Australia.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.